Cellectar Biosciences (CLRB) Return on Equity [ROE] (2011 - 2026)
Cellectar Biosciences' Return on Equity [ROE] came in at -123.80% for Q2 2026, up 413.37 percentage points from -537.17% a year earlier.
Powered by 
Analysis
Cellectar Biosciences (CLRB) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Cellectar Biosciences' Return on Equity [ROE] was -190.88%.
- Return on Equity [ROE] carries a five-year change of -142.99 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -170.85% in FY2022 (-113.32 pp) and -57.53% in FY2021 (-9.64 pp).
- The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] since Q2 2022.
- Year-over-year, Return on Equity [ROE] increased in two of the last four quarters, with an average year-over-year change of +70.21 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q2 2026 (a gain of 413.37 percentage points), and the weakest in Q1 2023 (a drop of 567.29 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Cellectar Biosciences | 21.77 Mn | 21.77 Mn | - | -123.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -123.80% |
| Dec 31, 2025 | -277.96% |
| Sep 30, 2025 | -426.55% |
| Jun 30, 2025 | -537.17% |
| Mar 31, 2025 | -409.59% |
| Dec 31, 2024 | -351.52% |
| Sep 30, 2024 | -374.51% |
| Jun 30, 2024 | -383.14% |
| Mar 31, 2023 | -658.93% |
| Dec 31, 2022 | -304.56% |
| Sep 30, 2022 | -190.48% |
| Jun 30, 2022 | -123.39% |
| Mar 31, 2022 | -91.63% |
| Dec 31, 2021 | -71.34% |
| Sep 30, 2021 | -53.31% |
| Jun 30, 2021 | -42.87% |
| Mar 31, 2021 | -33.84% |
| Dec 31, 2020 | -43.06% |
| Sep 30, 2020 | -82.16% |
| Jun 30, 2020 | -118.34% |
API Access
Cellectar Biosciences Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CLRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "CLRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CLRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();